The U.S. Department of Energy’s (DOE’s) Artificial Retina Project is a collaborative, multi-institutional effort to develop an implantable microelectronic retinal device that restores useful vision to people blinded by retinal diseases. The ultimate goal of the project is to restore reading ability, facial recognition, and unaided mobility in people with retinitis pigmentosa and age-related macular degeneration.

The project taps into the unique technologies and resources developed at DOE national laboratories to surmount the many technical challenges involved with developing a safe, effective, and durable product. The research team includes six DOE national laboratories, four universities, and private industry.

Three models are now in development or testing. Model 1, with 16 electrodes, has been implanted in six patients. Clinical trials for a second, more compact device with 60 electrodes are underway with U.S. Food and Drug Administration permission. A third, far less invasive and higher-resolution model is under development.

Clinical testing of the devices is supported by the National Eye Institute of the National Institutes of Health and others. For information on eligibility for participation in these studies, see Who is eligible?.

Watch a video about the Artificial Retina Project

Now Featuring

Wentai Liu, Microchip Developer [UCSC press release]

Artificial Retina News Issue 2

2nd Gen. Device Clinical Trials Underway

Implant Recipient Terry Byland's Story

Lab Spotlight: LLNL

PBS' Sci. American Frontiers Features Artificial Retina